Sign in

CIK 0001446847

  • Accelerated filer
  • Smaller reporting company

IRONWOOD PHARMACEUTICALS INC

Sign in to watch
Ticker
IRWD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043404176
Phone
+1 617-621-7722
Business address
100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-10 Shetzline Michael SVP, CMO, Head-Res&Drug Grant or award +136,612 658,037
2026-02-24 Shetzline Michael SVP, CMO, Head-Res&Drug Sale +17,012 $3.66 $62K 521,425
2026-02-23 Shetzline Michael SVP, CMO, Head-Res&Drug Sale −15,570 $3.81 $59K 538,437
2025-02-10 Shetzline Michael SVP, CMO, Head-Res&Drug Grant or award +133,333 595,276
2025-02-10 Shetzline Michael SVP, CMO, Head-Res&Drug Sale −41,269 $1.76 $73K 554,007
2025-01-17 Shetzline Michael SVP, CMO, Head-Res&Drug Grant or award +48,224 461,943
2024-05-20 Shetzline Michael CMO,SVP,Head-Res&Drug Sale −16,128 $6.45 $104K 413,719
2024-03-08 Shetzline Michael CMO,SVP,Head-Res&Drug Option exercise +34,936 429,847
2024-03-08 Shetzline Michael CMO,SVP,Head-Res&Drug Option exercise · Performance-based Restricted Stock Unit −34,936 0
2024-02-12 Shetzline Michael CMO,SVP,Head-Res&Drug Sale −38,618 $15.24 $589K 340,484
2024-02-12 Shetzline Michael CMO,SVP,Head-Res&Drug Grant or award +54,427 394,911
2024-02-12 Shetzline Michael CMO,SVP,Head-Res&Drug Grant or award · Performance-based Restricted Stock Unit +27,214 27,214
2024-01-17 Shetzline Michael CMO,SVP,Head-Res&Drug Grant or award +57,971 379,102
2023-05-22 Shetzline Michael CMO,SVP,Head-Res&Drug Sale −10,324 $10.12 $104K 321,131
2023-03-08 Shetzline Michael CMO,SVP,Head-Res&Drug Grant or award +69,869 331,455
2023-03-08 Shetzline Michael CMO,SVP,Head-Res&Drug Grant or award · Performance-based Restricted Stock Units +34,935 34,935
2023-02-28 Shetzline Michael CMO,SVP,Head-Res&Drug Sale −7,438 $11.31 $84K 264,002
2023-02-28 Shetzline Michael CMO,SVP,Head-Res&Drug Sale −2,416 $11.31 $27K 261,586
2023-02-27 Shetzline Michael CMO,SVP,Head-Res&Drug Sale −7,146 $11.41 $82K 273,762
2023-02-27 Shetzline Michael CMO,SVP,Head-Res&Drug Sale −2,322 $11.41 $26K 271,440

Page 1 of 2 · 31 trades